T-cell subsets in the long-term course of myasthenia gravis

1991 ◽  
Vol 4 (6) ◽  
pp. xxxviii
Author(s):  
P. Berlit
2021 ◽  
Vol 12 ◽  
Author(s):  
Trine H. Popperud ◽  
Kiran A. Gul ◽  
Cathrine Brunborg ◽  
Richard W. Olaussen ◽  
Tore G. Abrahamsen ◽  
...  

Thymectomy is an established treatment in adult MG and also recommended for the treatment of post-pubertal onset juvenile MG. Whether the youngest children should be thymectomized is still debated. Signs of premature aging of the immune system have been shown in studies on early perioperative thymectomy in children with congenital heart defect. In this retrospective cohort study the objective was to investigate the long-term effects of treatment related thymectomy on T cell subsets and T cell receptor rearrangement excision circles (TRECs) in peripheral blood of juvenile myasthenia gravis (MG) patients, as well as clinical occurrence of autoimmune disorders, malignancies and infectious diseases. Forty-seven patients with onset of myasthenia gravis before the age of 19 years were included; 32 (68.1%) had been thymectomized and 15 (31.8%) had not. They were studied at varying times after thymectomy (7–26 years). We found a significant lower number of naïve helper T cells (CD4+CD45RA+) with an increased proportion of memory helper T cells (CD4+CD45RO+), and a significant lower number of naïve cytotoxic T cells (CD8+CD27+CD28+) in the thymectomized patients. In addition they showed a significant reduction in the number of TRECs and proportion of recent thymic emigrants (RTE) compared to non-thymectomized patients. In none of them an increased frequency of malignancies or infections was found. Our findings indicate a premature aging of the immune system after thymectomy in juvenile MG, but associated clinical consequences could not be verified.


Blood ◽  
1997 ◽  
Vol 90 (9) ◽  
pp. 3662-3672 ◽  
Author(s):  
Nobukazu Watanabe ◽  
Stephen C. De Rosa ◽  
Anthony Cmelak ◽  
Richard Hoppe ◽  
Leonore A. Herzenberg ◽  
...  

Abstract We investigated the representation of T cells in patients who had been treated for Hodgkin's disease (HD). We found a marked depletion in both CD4 and CD8 naive T-cell counts that persists up to 30 years after completion of treatment. In contrast, CD4 and CD8 memory T-cell subsets recovered to normal or above normal levels by 5 years posttreatment. Thus, the previously-reported long-term deficit in total CD4 T-cell counts after treatment for HD is due to specific depletion of naive T cells. Similarly, total CD8 T-cell counts return to normal by 5 years only because CD8 memory T cells expand to higher than normal levels. These findings suggest that the treatment (mediastinal irradiation) results in a longterm dysregulation of T-cell subset homeostasis. The profound depletion of naive T cells may explain the altered T-cell function in treated patients, including the poor response to immunization after treatment for HD. Further, in some individuals, we identified expansions of unusual subsets expressing low levels of CD8. Eight-color fluorescence-activated cell sorting analyses showed that these cells largely express CD8αα homodimers and CD57, consistent with the phenotype of potentially extrathymically derived T cells. In addition, these cells, both CD4+ and CD4−, are probably cytotoxic lymphocytes, as they express high levels of intracellular perforin. In adults treated for HD, an increased activity of extrathymic T-cell differentiation may partially compensate for the loss of thymic-derived T cells.


2018 ◽  
Vol 13 (10) ◽  
pp. S399 ◽  
Author(s):  
J. Murakami ◽  
L. Wu ◽  
M. Kohno ◽  
M. Chan ◽  
Y. Zhao ◽  
...  

Neurology ◽  
1984 ◽  
Vol 34 (1) ◽  
pp. 66-66 ◽  
Author(s):  
S. Berrih ◽  
E. Morel ◽  
C. Gaud ◽  
F. Raimond ◽  
H. L. Brigand ◽  
...  

1990 ◽  
Vol 131 (1) ◽  
pp. 191-204 ◽  
Author(s):  
Angelika Grossmann ◽  
Lillian Maggio-Price ◽  
John C. Jinneman ◽  
Norman S. Wolf ◽  
Peter S. Rabinovitch

2021 ◽  
Author(s):  
Zhiliang Bai ◽  
Steven Woodhouse ◽  
Dongjoo Kim ◽  
Stefan Lundh ◽  
Hongxing Sun ◽  
...  

Chimeric antigen receptor modified (CAR) T cells targeting CD19 have mediated dramatic responses in relapsed or refractory acute lymphoblastic leukemia (ALL), yet a notable number of patients have CD19-positive relapse within one year of treatment. It remains unclear if the long-term response is associated with the characteristics of CAR T cells in infusion products, hindering the identification of biomarkers to predict therapeutic outcomes prior to treatment. Herein we present 101,326 single cell transcriptomes and surface protein landscape from the CAR T infusion products of 12 pediatric ALL patients upon CAR antigen-specific stimulation in comparison with TCR mediated activation and controls. We observed substantial heterogeneity in the antigen-specific activation states, among which a deficiency of Th2 function was associated with CD19 positive relapsed patients (median remission 9.6 months) compared with very durable responders (remission over 54 months). Proteomic profiles also revealed that the frequency of early memory T cell subsets, rather than activation or co-inhibitory signatures could distinguish CD19-positive relapse. Additionally, a deficit of type 1 helper and cytotoxic effector function and an enrichment for terminally differentiated CD8+ T cells exhibiting low cytokine polyfunctionality was associated with initial non-responders. By contrast, the single-cell transcriptomic data of unstimulated or TCR-activated CAR T cells failed to predict clinical responses. In aggregate, our results dissect the landscape of CAR-specific activation states in infusion products that can identify patients who do not develop a durable response to the therapy, and unveil the molecular mechanisms that may inform strategies to boost specific T cell function to maintain long term remission.


AIDS ◽  
2019 ◽  
Vol 33 (4) ◽  
pp. 627-636 ◽  
Author(s):  
Gabriella d’Ettorre ◽  
Cristian Borrazzo ◽  
Claudia Pinacchio ◽  
Letizia Santinelli ◽  
Eugenio N. Cavallari ◽  
...  
Keyword(s):  
T Cell ◽  
Ifn Γ ◽  

1996 ◽  
Vol 2 (4) ◽  
pp. 452-459 ◽  
Author(s):  
Dulceaydee Gigliotti ◽  
Ann-Kari Lefvert ◽  
Mahmood Jeddi-Tehrani ◽  
Semih Esin ◽  
Vida Hodara ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document